her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
Published 3 years ago • 181 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
2:08
recent progress in managing brain metastasis in breast cancer
-
3:15
brain metastases in her2 breast cancer
-
1:40
her2climb study shows efficacy in her2 breast cancer with brain metastases
-
3:15
her2climb-02: tucatinib tdm-1 in advanced breast cancer
-
1:30
tucatinib in her2 breast cancer with leptomeningeal metastases
-
2:01
her2climb: tucatinib in combination w/ capecitabine & trastuzumab
-
2:10
treating cns metastases in her2 breast cancer
-
1:16
her2climb-04: tucatinib plus t-dxd for her2 breast cancer
-
1:12
her2climb-04: tucatinib trastuzumab deruxtecan in her2 breast cancer
-
2:20
can we prevent brain metastases in breast cancer?
-
1:11
32 month follow-up of mountaineer: tucatinib and trastuzumab in her2 mcrc
-
1:56
treating her2 breast cancer with brain metastases
-
3:05
pi3k inhibitors for the treatment of brain metastases in her2-negative breast cancer
-
1:47
her2climb-05: tucatinib trastuzumab and pertuzumab as maintenance therapy for her2 metastatic bc
-
3:45
her2climb: implications for brain metastases in her2 mbc
-
5:55
decision-making in metastatic her2 breast cancer
-
0:38
treatment updates for breast cancer with brain metastases
-
1:46
choosing between tucatinib and t-dxd in her2 breast cancer